In last trading session, Virios Therapeutics Inc (NASDAQ:VIRI) saw 0.36 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price level of $0.51 trading at $0.03 or 6.77% at ring of the bell on the day assigns it a market valuation of $9.87M. That closing price of VIRI’s stock is at a discount of -374.51% from its 52-week high price of $2.42 and is indicating a premium of 45.1% from its 52-week low price of $0.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.27 million shares which gives us an average trading volume of 385.79K if we extend that period to 3-months.
Virios Therapeutics Inc (NASDAQ:VIRI) trade information
Upright in the green during last session for gaining 6.77%, in the last five days VIRI remained trading in the green while hitting it’s week-highest on Friday, 04/12/24 when the stock touched $0.51 price level, adding 3.37% to its value on the day. Virios Therapeutics Inc’s shares saw a change of -10.89% in year-to-date performance and have moved 11.88% in past 5-day. Virios Therapeutics Inc (NASDAQ:VIRI) showed a performance of 63.18% in past 30-days. Number of shares sold short was 0.22 million shares which calculate 0.39 days to cover the short interests.
Virios Therapeutics Inc (VIRI) estimates and forecasts
Statistics highlight that Virios Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -33.97% of value to its shares in past 6 months, showing an annual growth rate of 3.57% while that of industry is 13.30. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 50.00% in the current quarter and calculating 50.00% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.02% during past 5 years.
VIRI Dividends
Virios Therapeutics Inc is more likely to be releasing its next quarterly report in May and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Virios Therapeutics Inc (NASDAQ:VIRI)’s Major holders
Insiders are in possession of 9.71% of company’s total shares while institution are holding 8.09 percent of that, with stock having share float percentage of 8.96%. Investors also watch the number of corporate investors in a company very closely, which is 8.09% institutions for Virios Therapeutics Inc that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at VIRI for having 0.21 million shares of worth $0.29 million. And as of Jun 29, 2023, it was holding 1.10% of the company’s outstanding shares.
The second largest institutional holder is Geode Capital Management, LLC, which was holding about 0.15 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 0.77% of outstanding shares, having a total worth of $0.2 million.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 0.21 million shares of worth $0.29 million or 1.09% of the total outstanding shares. The later fund manager was in possession of 0.13 million shares on May 30, 2023, making its stake of worth around $0.23 million in the company or a holder of 0.70% of company’s stock.
